The worst performer was my largest holding OPTI:Optibiotix, which dropped 1p and lost over £2,000 in value, so the fact the weekly drop was only £584 shows how well some other shares did.
SBTX:SkinBioTherapeutics is another of my biggest holdings and dropped 12% probably due to one large shareholder having sold out.
ALU:Alumasc Group dropped 8% for no reason but my holding is still 20% up overall. They have had a pretty massive fall over the last few months, with shareholders worried about increasing costs and potentially smaller profits. I've re-calculated my magic formula rankings based on their recent performance and they drop to 28th, but that's still in the top 50, so I'll only sell if they drop outside that.
AMP:Ampeak Energy dropped 7% for no obvious reason.
FDM:FDM Group continue to slide after I thought they were staging a recovery, but they fell 6% this week to go 60% down.
POLR:Polar Capital were having a great run, but it seems to be over, with a drop of 5% this week leaving my holding only just in the black.
AMRQ:Amaroq released amazing drilling results, but only managed to climb 5%, but that was enough to put my SIPP holding back into profit and my ISA holding is 14% up.
TLOU:Tlou Energy continue to yo-yo and went up 6% this week.
TRU:Trufin climbed 6% and are now 10% up in my ISA.
AFC:AFC Energy continue to surge, with another 7% gain this week leaving my holding only down 26%.
FXPO:Ferrexpo is another yo-yo stock that would be great for trading. They went up 8% this week so my holding is now 85% down.
GGP:Greatland Resources had a splendid week, climbing 13% to go 69% up overall.
Share of the Week is PBX:Probiotix Health which went up 17% and is now 66% down. I suspect that the person selling a big chunk of SBTX:SkinBioTherapeutics may have put it here and caused a short term blip, as there's no sign of longer term price support.
Here's the ISA and shares portfolio after week 20 of year 11.
| Weekly Change | |||
| Cash | £127.12 | +£40.01 | |
| Portfolio cost | £116,758.09 | +£0 | |
| Portfolio sell value (bid price-commission) | £34,412.45 | (-70.5%) | -£378.99 |
| Potential profits | £246.45 | +£128.94 | |
| Yr 11 Dividends | £69.36 | +£44.04 | |
| Yr 11 Interest | £0.75 | +£0 | |
| Yr 11 Profit from sales | £487.56 | +£0 | |
| Yr 11 proj avg monthly profit | £112.25 | (1.5%) | +£3.21 |
| Total Dividends | £12,557.43 | +£44.04 | |
| Total Interest | £9.32 | +£0 | |
| Total Profit from sales | £18,047.83 | +£0 | |
| Average monthly cash profit | £240.81 | (3.3%) | -£0.13 |
| (Sold stocks profit + Dividends - Fees / Months) |
I got a £44 dividend from ASHM:Ashmore Group minus monthly fees from AJ Bell. Potential profits are up £128 thanks to AMRQ:Amaroq and TRU:Trufin both having good weeks and despite BOKU:Boku sliding to a loss. The drop in portfolio value was pretty small all things considered.
Not the bounce I was hoping for as we lead into Christmas
Staying on the trend line
The SIPP looks like this after week 524 overall and week 4 of year 11.
| Weekly Change | ||||
| Cash | £802.90 | -£547.47 | ||
| Portfolio cost | £143,804.05 | +£707.67 | ||
| Portfolio sell value (bid price - commission) | £78,478.27 | (-45.4%) | -£205.29 | |
| Potential profits | £9,436.46 | +£525.56 | ||
| Yr 11 Dividends | £198.87 | +£163.67 | ||
| Yr 11 Interest | £0 | +£0 | ||
| Yr 11 Profit from sales | £800.74 | +£0 | ||
| Yr 11 proj avg monthly profit | £1,061.11 | (13.7%) | -£122.30 | |
| Total Dividends | £18,419.07 | +£163.67 | ||
| Total Interest | £20.70 | +£0 | ||
| Total Profit from sales | £25,467.25 | +£0 | ||
| Average monthly cash profit | £349.53 | (4.5%) | +£0.66 |
I did my monthly investments. First I continued buying RAT:Rathbones. I bought 13 shares at 1821p costing £239.41. Unfortunately they promptly dropped to 1780p so my timing wasn't great. I have one more month of buying RAT.
Next I added to my position in SCT:Softcat as I think the recent drop is unjustified. I bought 17 shares at 1423.9255p costing £244.78. I'll buy more next month if they continue to remain depressed.
Finally I bought back into III:3i Group after their recent share price collapse, as I think it was over-done. It does however mean I was right to sell them when I suspected they were over valued. I bought 7 shares at 3155.497p costing £223.48.
I had an impressive £163 in dividends, made up of £49 from JHD:James Halstead, £12 from KNOS:Kainos Group and £102 from PAF:Pan African Resources.
Potential profits went up by £525 because many profitable shares had a good week, and that reduced the losses from the big fallers to just £205.
The gap to injection has been remarkably constant, but isn't improving.
Fractionally above the trend line
Again just above the trend line.
The gap to injection has been remarkably constant, but isn't improving.
Fractionally above the trend line
Again just above the trend line.
If there's going to be a Santa rally then it needs to be next week, but I can't see where it's going to come from. I only have enough cash in my SIPP to do one more month of multiple regular investments. I'd love to be able to boost that pot before 10th February else I'll have to go back to just the one monthly purchase from my regular savings.
News came through that my DDDD:4D Pharma shares are officially worthless and they have been cancelled. I was holding out a tiny hope they'd get something for selling the IP, but it at least ends the chapter of my worst ever investment, losing £18,600. That disaster is going to impact my performance for a long time to come, and I know it won't be the last as TRX:Tissue Regenix will be dead very soon, as will KIBO:Kibo Energy, and between them they will lose me £6,000. If OPTI:Optibiotix goes bust then I may as well give up.
No comments:
Post a Comment